Source: BioPortfolio

Achaogen: Achaogen Eyes Sale in Bankruptcy Auction a Year After FDA Approval

Achaogen wants to sell itself through an auction as a part of a Chapter 11 bankruptcy reorganization which the antibacterialproduct maker announced it filed for this morning. Achaogen plans to continue its normal business operations through the Chapter 11 ...

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
Blake Wise's photo - CEO of Achaogen

CEO

Blake Wise

CEO Approval Rating

77/100

Read more